A detailed history of Waypoint Wealth Counsel transactions in Abbott Laboratories stock. As of the latest transaction made, Waypoint Wealth Counsel holds 2,230 shares of ABT stock, worth $284,614. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,230
Previous 1,644 35.64%
Holding current value
$284,614
Previous $218 Million 39.03%
% of portfolio
0.15%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 25, 2025

BUY
$123.95 - $138.08 $72,634 - $80,914
586 Added 35.64%
2,230 $303 Million
Q1 2025

Apr 23, 2025

BUY
$111.1 - $140.22 $182,648 - $230,521
1,644 New
1,644 $218 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Waypoint Wealth Counsel Portfolio

Follow Waypoint Wealth Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Wealth Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Wealth Counsel with notifications on news.